The summary below is from the full report titled “Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical Trial.” It is in the 15 October 2002 issue of Annals of Internal Medicine (volume 137, pages 640-647). The authors are RM Jasmer, JJ Saukkonen, HM Blumberg, CL Daley, J Bernardo, E Vittinghoff, MD King, LM Kawamura, and PC Hopewell, for the Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators.
Short-Course Treatment for Latent Tuberculosis Is Associated with More Frequent Liver Injury Than Long-Course Treatment Is. Ann Intern Med. 2002;137:I–32. doi: https://doi.org/10.7326/0003-4819-137-8-200210150-00002
Download citation file:
Published: Ann Intern Med. 2002;137(8):I-32.
Emergency Medicine, Gastroenterology/Hepatology, Infectious Disease, Liver Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use